830 Hyderabad-based Bharat Biotech and the Indian Council for Medical Research have developed Covaxin, one of the two vaccines being used in the ongoing nationwide COVID-19 vaccination drive. PTI file
New Delhi, April 16
The production of indigenously developed COVID-19 vaccine Covaxin will be ramped up significantly and increased to 10 crore doses per month by September, the Department of Biotechnology said on Friday.
Covaxin’s production will be doubled by May-June and the department has roped in three public sector companies to increase the capacity of vaccine production, it said.
Few weeks ago, inter-ministerial teams had visited the sites of two main vaccine manufacturers in India to get their inputs on how production can be ramped up.
Govt augments manufacturing capacity for COVAXIN production
Govt augments manufacturing capacity for COVAXIN production
16 April 2021 | News
Image credit- shutterstock.com
As a part government s augmentation plan, capacities of Bharat Biotech Limited, Hyderabad as well as other public sector manufacturers are being upgraded with required infrastructure and technology.
Financial support is being provided as grant from GoI to the tune of appx Rs 65 Cr to Bharat Biotech’s new Bangalore facility which is being repurposed to increase the capacity of vaccine production.
3 public sectors companies are also being supported to increase the capacity of vaccine production.
The Department of Science & Technology (DST), GoI, has granted approval to Haffkine Institute to produce Bharat Biotech s Covaxin vaccine on a transfer of technology basis.
Covid-19: Centre ropes in PSUs to ramp up vaccine production
Top Searches
Covid-19: Centre ropes in PSUs to ramp up vaccine production
PTI / Apr 16, 2021, 18:24 IST
FacebookTwitterLinkedinEMail
NEW DELHI: The production of indigenously developed Covid-19 vaccine Covaxin will be ramped up significantly and increased to 10 crore doses per month by September, the Department of Biotechnology said on Friday.
Covaxin s production will be doubled by May-June and the department has roped in three public sector companies to increase the capacity of vaccine production, it said.
Few weeks ago, inter-ministerial teams had visited the sites of two main vaccine manufacturers in India to get their inputs on how production can be ramped up.
1777 Registering a steady rise for the 37th day in a row, the active cases rose to 15,69,743, comprising 10.98 per cent of the total infections. Tribune Photo: Mukesh Aggarwal
New Delhi, April 16
As India recorded over two lakh new COVID-19 cases for the second straight day, the Centre on Friday unveiled plans to ramp up output of indigenous vaccine Covaxin ten times to reach 10 crore doses by September and accelerate the manufacture of antiviral drug remdesivir, and also called for increasing the production of medical oxygen.
In the wake of reports of shortage of the medical grade oxygen for COVID-19 patients in different parts of the country in the last few days, Prime Minister Narendra Modi undertook a comprehensive review to ensure its adequate supply, and said steps should be taken to augment the production. He also asked officials to ensure seamless and free movement of tankers carrying this commodity throughout the country.
AP CM writes to PM seeking 60 lakh doses of COVID-19 pakistantelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pakistantelegraph.com Daily Mail and Mail on Sunday newspapers.